New avenues for targeted therapies and biomarkers in anaplastic large cell lymphoma

Epigenomics. 2017 Feb;9(2):97-100. doi: 10.2217/epi-2016-0159. Epub 2017 Jan 18.
No abstract available

Keywords: DNA methylation; NPM-ALK; anaplastic large cell lymphoma; crizotinib.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anaplastic Lymphoma Kinase
  • Biomarkers, Tumor*
  • DNA Methylation / genetics
  • Epigenesis, Genetic / drug effects
  • Humans
  • Lymphoma, Large-Cell, Anaplastic / diagnosis
  • Lymphoma, Large-Cell, Anaplastic / drug therapy*
  • Lymphoma, Large-Cell, Anaplastic / genetics*
  • Lymphoma, Large-Cell, Anaplastic / metabolism
  • Molecular Targeted Therapy*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
  • Receptor Protein-Tyrosine Kinases / genetics

Substances

  • Biomarkers, Tumor
  • Protein Kinase Inhibitors
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases